Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Immunoadsorption successfully treated a man's resistant polymyositis.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Exosomes show promise as effective treatments for autoimmune skin diseases with fewer side effects.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

ICD codes for skin conditions vary in accuracy, needing better validation for some common conditions.

Consider DRIF and perform skin biopsies for persistent papular rashes.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Early skin biopsy helps diagnose and manage severe skin conditions in babies.

Current methods for assessing bioequivalence of topical drugs are limited and lack standardization.

A kidney transplant and immunosuppressive treatment stopped the skin disease in a patient.

The woman's widespread skin condition did not improve despite various treatments.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Early recognition and treatment of VATS in transplant patients improve outcomes.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Some elderly men had healing problems after using imiquimod and diclofenac for skin conditions on their scalps.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Trichostasis spinulosa can be diagnosed with a simple skin biopsy and treated with specific gels, but lesions may return after stopping treatment.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

A new system was created to classify skin changes in cancer patients based on their treatment.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.